Radiolabeled TSPO Targeted Molecular Probe in AMI

NCT07105982 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 8

Last updated 2025-08-06

No results posted yet for this study

Summary

Evaluate the clinical application value of the novel radiolabeled TSPO-targeted molecular probe Gallium \[68Ga\]-DOTA-HK-011 for inflammation imaging associated with acute myocardial infarction.

Conditions

  • Acute Myocardial Infarction (AMI)

Sponsors & Collaborators

  • Nanjing First Hospital, Nanjing Medical University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-01
Primary Completion
2026-08-31
Completion
2026-08-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07105982 on ClinicalTrials.gov